Equity Overview
Price & Market Data
Price: $4.97
Daily Change: -$0.02 / 0.40%
Range: $4.97 - $4.99
Market Cap: $261,168,608
Volume: 541,909
Performance Metrics
1 Week: 0.40%
1 Month: 0.81%
3 Months: 98.80%
6 Months: 0.40%
1 Year: 7.31%
YTD: 69.73%
Company Details
Employees: 65
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. 2seventy bio, Inc. was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.